Successful thalidomide therapy for actinic prurigo in a European woman

J Dtsch Dermatol Ges. 2006 Nov;4(11):961-4. doi: 10.1111/j.1610-0387.2006.06125.x.
[Article in English, German]

Abstract

Actinic prurigo is a rare, often difficult-to-treat, idiopathic photodermatosis. Actinic prurigo is divided into a hereditary form appearing in the Native American population and a sporadic form occurring in non-Native Americans. We present a 28-year-old Caucasian woman who developed typical clinical signs and symptoms of actinic prurigo, just as had her mother and grandmother. The patient and her mother were HLA-A24 and HLA-DR 4 with the subtype HLA-DRB1*0408. Based on clinical symptoms and the HLA pattern, the diagnosis of actinic prurigo was made. Treatment with thalidomide led to resolution of the disease. This case report of a Caucasian woman suffering from a hereditary form of actinic prurigo questions the established classification of actinic prurigo into a hereditary Native American form and a sporadic form occurring in the non-Native American population.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Europe
  • Female
  • Humans
  • Photosensitivity Disorders / complications
  • Photosensitivity Disorders / diagnosis*
  • Photosensitivity Disorders / drug therapy*
  • Prurigo / complications
  • Prurigo / diagnosis
  • Prurigo / therapy*
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Thalidomide